NCT05669573

Brief Summary

The purpose of this study is to evaluate the safety of eating 6 hours after Extracorporeal Shock Wave Lithotripsy (ESWL). At present, ESWL and Endoscopic Retrograde Cholangiopancreatography (ERCP) are the routine ways to treat pancreatic duct stones. For large stones (diameter \> 5mm) , ESWL often needs to be performed many times. In clinical practice, fasting for 24 hours after surgery is often used, but long-term fasting brings strong discomfort to patients. However, the consensus for initiation timing of oral nutrition has not yet been established after ESWL. Thus, we design this trial to evaluate the safety of early feeding based on 6 hours parameter instead of the consensus definition.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
216

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 20, 2022

Completed
14 days until next milestone

First Posted

Study publicly available on registry

January 3, 2023

Completed
5 months until next milestone

Study Start

First participant enrolled

May 29, 2023

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 17, 2024

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 22, 2024

Completed
Last Updated

March 28, 2025

Status Verified

March 1, 2025

Enrollment Period

11 months

First QC Date

December 20, 2022

Last Update Submit

March 25, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • the incidence of post-ESWL pancreatitis

    A diagnosis of post-ESWL pancreatitis was thus made if two of three of the following criteria were met, in accordance with the revised Atlanta international consensus: pain consistent with pancreatitis; amylase or lipase of at least three times the upper normal limit within 24 h of the procedure; or characteristic findings on imaging.

    within 24 hours after ESWL

Secondary Outcomes (5)

  • the severity of post-ESWL pancreatitis

    within 24 hours after ESWL

  • the incidence of other post-ESWL complications

    within 24 hours after ESWL

  • the transient adverse events

    within 24 hours after ESWL

  • abdominal pain relief rate

    within 24 hours after ESWL

  • hunger relief rate

    within 24 hours after ESWL

Study Arms (2)

Early feeding group

EXPERIMENTAL

Patients in the early diet group started oral intake 6 hours after ESWL of the day of procedure with a soft diet comprised 200 mL with 170 kilocalories. Observe closely until 24h, and then continue to fasting until the next ESWL/ERCP or change the diet to the general diet according to the actual clinical needs.

Procedure: Early feeding group

Standard fasting group

ACTIVE COMPARATOR

Patients in the standard fasting group were fasted for 24 hours after the first ESWL operation, and close observation during this fasting period. After 24 hours, according to the actual clinical needs, continue to fast until the next ESWL/ERCP operation, or change the diet to a general diet.

Procedure: Standard fasting group

Interventions

Patients in the early diet group started oral intake 6 hours after ESWL of the day of procedure with a soft diet comprised 200 mL with 170 kilocalories.

Early feeding group

Patients in the standard fasting group were fasted for 24 hours after the first ESWL operation, and close observation during this fasting period.

Standard fasting group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with chronic pancreatitis who completed ESWL.

You may not qualify if:

  • Readmitted to the hospital during enrollment of the study;
  • Cannot eat or rely on jejunal nutrition tube to give total parenteral nutrition for various reasons;
  • With acute pancreatitis, perforation, infection, bleeding, steinstrasse and other complications and other serious clinical adverse events within 6 hours after ESWL;
  • Suspected or confirmed malignancy
  • Pancreatic ascites;
  • Coagulation dysfunction;
  • Taking chemotherapy drugs and immunosuppressants for a long time;
  • Acute pancreatitis exacerbation or acute exacerbation of chronic pancreatitis (including biliary pancreatitis);
  • Pregnant or breastfeeding women;
  • Patients who refused to participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Changhai Hospital

Shanghai, 200433, China

Location

Related Publications (1)

  • Hao L, Liu Y, Xie T, Wang T, Guo HL, Pan J, Wang D, Bi YW, Ji JT, Xin L, Du TT, Lin JH, Zhang D, Zeng XP, Zou WB, Chen H, Li BR, Liao Z, Cong ZJ, Shi RH, Li ZS, Hu LH. Risk Factors and Nomogram for Pancreatic Stone Formation in Chronic Pancreatitis over a Long-Term Course: A Cohort of 2,153 Patients. Digestion. 2020;101(4):473-483. doi: 10.1159/000500941. Epub 2019 Jun 25.

    PMID: 31238312BACKGROUND

MeSH Terms

Conditions

Fasting

Condition Hierarchy (Ancestors)

Feeding BehaviorBehavior

Study Officials

  • Liang-hao Hu, MD

    Changhai Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

December 20, 2022

First Posted

January 3, 2023

Study Start

May 29, 2023

Primary Completion

April 17, 2024

Study Completion

April 22, 2024

Last Updated

March 28, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations